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ABSTRACT
Background: Intellectual disability (ID) carries a high
impact on need for care, health status and premature
mortality. Respiratory system diseases contribute a
major part of mortality among people with ID, but
remain underinvestigated as consequent morbidities.
Methods: Anonymised electronic mental health
records from the South London and Maudsley Trust
(SLaM) were linked to national acute medical care data.
Using retrospective cohort and matched case–control
study designs, adults with ID receiving SLaM care
between 1 January 2008 and 31 March 2013 were
identified and compared with local catchment residents
for respiratory system disease admissions.
Standardised admission ratios (SARs) were first
calculated, followed by a comparison of duration of
hospitalisation with respiratory system disease between
people with ID and age-matched and gender-matched
random counterparts modelled using linear regression.
Finally, the risk of readmission for respiratory system
disease was analysed using the Cox models.
Results: For the 3138 adults with ID identified in
SLaM, the SAR for respiratory system disease
admissions was 4.02 (95% CI 3.79 to 4.26).
Compared with adults without ID, duration of
hospitalisation was significantly longer by 2.34 days
(95% CI 0.03 to 4.64) and respiratory system disease
readmission was significantly elevated (HR=1.35; 95%
CI 1.17 to 1.56) after confounding adjustment.
Conclusions: Respiratory system disease admissions
in adults with ID are more frequent, of longer duration
and have a higher likelihood of recurring. Development
and evaluation of potential interventions to the
preventable causes of respiratory diseases should be
prioritised.
INTRODUCTION
Intellectual disability (ID) is deﬁned as a
mental disorder with substantially reduced
ability to understand new or complex infor-
mation, to learn new skills and to cope inde-
pendently, evident during the developmental
period in childhood with a lasting effect into
adulthood.1 The prevalence of ID in
England is estimated to be around 2% in
adults,2 with an estimated 1.07 million
people affected and 0.9 million aged 18 years
or above in 2013.3 Among them, only around
5 per 1000 are known to medical services.4
Healthcare of people with ID has been
a longstanding concern, with increasingly
recognised inequalities in access to health-
care, higher multimorbidity burden, poorer
health outcomes and premature mortality.5–9
Based on a nationwide hospital discharge
register system in Sweden, Auquier et al10
revealed substantial losses in life expectancy
for various mental disorder categories com-
pared with the general population, including
14.7 life years of life lost for adults with ID.
A UK population-based study for a speciﬁc
group of people with moderate to severe ID
revealed higher than 8-fold and 17-fold
Strengths and limitations of this study
▪ A nearly population-based dynamic mental dis-
order cohort in London with a massive data
linkage to the national case register system of
hospital admission in England.
▪ Diagnosis of intellectual disability (ID) in second-
ary mental healthcare was relatively more precise
than community studies.
▪ Data were routinely collected in clinical settings,
not particularly generated for research purposes,
resulting in missing lifestyle factors (ie, smoking,
alcohol intake, physical activity and obesity) for
confounding control.
▪ For the nature of secondary mental health
systems, ID patients in adulthood might be
underestimated, which limited the generalisability
of this study.
▪ We only focused on hospital admissions of
respiratory system diseases with ignorance of
milder cases as the outcomes.
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increases in standardised mortality for men and women,
respectively.8 People with ID have been found to consult
GPs more often (82% vs 69%),11 and are twice as likely
to be admitted into hospital for a physical illness (26%
vs 14%) compared with the general population.12 Eight
per cent of admissions end up as emergency admissions
compared with 5% for the general population, and,
unlike the general population, emergency admissions
occur across the age groups and not predominantly in
the very young or elderly.13
The Conﬁdential Inquiry into Premature Deaths of
People with Learning Disabilities (CIPOLD) reported that
42% of the deaths they reviewed were considered prema-
ture and avoidable, either through improved quality of
care or effective public health interventions.14 The most
common reasons were delays or barriers to diagnoses and
treatments, although it has been suggested that the
inequalities evident in access to healthcare may place many
the National Health Service (NHS) Trusts in England in
contravention of their legal responsibilities under the
Equality Act 2010, the Mental Capacity Act 2005 and the
Health and Social Care Act 2008 (Regulated Activities)
Regulations 2010.15 There is therefore a pressing need to
better characterise the pattern of medical service use
among people with ID, in order to reduce health inequal-
ities, improve coordination of care for their long-term con-
ditions and reduce the risk of premature death.16
Chronic physical conditions, including lung diseases,
have been reported more frequently among people with
a wide range of mental disorders.17 Respiratory system
disease has been highlighted as a particularly important
physical health issue in people with ID, affecting 46–
52% of the ID population, compared with 15–17% in
the general population.18 In the UK, respiratory system
disease was documented as the leading cause in death
certiﬁcations for people with ID; however, ID itself was
rarely recorded in the death certiﬁcates.5 Although pub-
lished research to date has focused on people with a
wide range of severity for ID, restrictions by small
samples, short follow-up periods and limited sample rep-
resentativeness existed.19–23 Speciﬁcally, an elevated risk
of mortality from bronchopneumonia of around 6.5-fold
was reported in a cohort with moderate to severe ID in
the UK,21 and respiratory infection was found the most
common cause of death over a 1-year period in a UK
cohort of adults with ID receiving mealtime support for
any eating, drinking or swallowing problem.20 In a
Taiwanese institutional sample of people with ID fol-
lowed for up to 4 years, pneumonia was the topmost
reason for hospitalisation.19 Another study in Canada
reported a more than twofold adjusted relative risk of
asthma admission of people with ID, identiﬁed by
population-based medical and educational databases,
comparing to people without ID.24 Issues about knowl-
edge level of inhaled asthma medications and asthma
management practice among milder ID patients
comorbid with asthma were also assessed by descriptive
and qualitative studies in Australia.22 23
Therefore, the unsolved research questions are about
how ID affects the risks of severe respiratory diseases
leading to admission and how much worse their treat-
ment outcomes are by comparing critical indicators for
service usage. To address these critical questions con-
cerning the speciﬁc usage of healthcare for adults with
ID,11 25 we carried out a series of analyses in a retro-
spective cohort of adults with ID known to secondary
care mental health services to investigate frequencies of
hospitalisation with respiratory system diseases, duration
of hospitalisation and risk of readmission, compared
with samples within the same catchment area over a
follow-up period of up to 5.25 years. Our analysis pro-
vided more evidence about the health disadvantages for
adults with ID, focusing on respiratory diseases, in order
to assess the impact of ID to inform the prevention strat-
egies for this potentially vulnerable group.
MATERIALS AND METHODS
Study setting
Details of the study setting are described elsewhere.26 In
brief, the South London and Maudsley NHS Foundation
Trust (SLaM) is one of the largest secondary mental
healthcare providers in Western Europe, serving ∼1.36
million residents in southeast London by providing a
range of secondary and tertiary mental healthcare ser-
vices. Since 2006, all clinical records in SLaM services
have been converted into electronic form and were
made available for research in 2008 by the establishment
of Clinical Record Interactive Search (CRIS), an anon-
ymised platform with full clinical information, under the
support of the National Institute of Health Research
(NIHR). The resulting SLaM Case Register was
approved as an anonymised data set for secondary data
analyses by the Oxfordshire Research Ethics Committee
C (reference number: 08/H0606/71+5). Several studies
using the CRIS data resource to investigate physical
health consequences of mental disorders have been
published.27–29
Study sample
A CRIS search was performed to deﬁne people with ID,
based on structured WHO ICD-10 diagnostic codes of
F70–F79 (mental retardation) entered before the end of
the observation period (31 March 2013). This was sup-
plemented by a natural language processing application
developed using Generalised Architecture for Text
Engineering (GATE) to identify text strings associated
with diagnostic statements. The study samples were at
least 20 years old at the midpoint of the observation
period (1 January 2008–31 March 2013) and had been
referred to or were under active review by SLaM services
at any time during the period. A pre-existing data
linkage was used between CRIS and Hospital Episodes
Statistics (HES) data to identify any hospitalisation
episode with an associated primary discharge diagnosis
of respiratory system disease (ICD-10 J codes). This
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linked ﬁle was generated by the NHS Health and Social
Care Information Centre (now NHS Digital), and con-
tains details of all admissions to NHS hospitals in
England and Wales for people who are resident in the
SLaM catchment, along with a link variable ascertaining
their CRIS record, for those who have received SLaM
care.
Statistical analyses
Schemes of analyses
With the major interest being ID, there were three
schemes of analyses: (1) standardised admission ratios
(SARs) during the observation period for any respiratory
system disease, and then for each major category of
respiratory system disease; (2) duration of hospitalisa-
tion, deﬁned as the number of days between admission
and discharge dates for the ﬁrst admission episode
(where both dates were available) during the observa-
tion period with respiratory system diseases as a primary
discharge diagnosis; and (3) risk of readmission with
respiratory system disease as a diagnosis following such
an admission episode.
Standardised admission ratios
In the ﬁrst comparison, SARs were calculated for people
with ID in relation to the SLaM catchment population,
with the age and gender structure derived from the
2011 UK Census for the catchment in order to calculate
expected admission numbers. SARs were calculated for
the observation period from 1 January 2008 to 31 March
2013 for all admissions where respiratory system disease
was given as the primary discharge diagnosis and then
for each major category of ICD-10 J code, using the
number of admissions recorded in HES as the numer-
ator (observed number). The denominator was the
expected number of admissions estimated by age-
speciﬁc, gender-speciﬁc and admission year-speciﬁc
admission rates for the local population multiplied by
the age and gender structure in the catchment area
given by the 2011 UK Census data. Each age stratum was
deﬁned at the midpoint of the observation period and
divided into 5-year groups (from 20–24 to 90+). SARs
were also calculated by gender and for patient counts by
eliminating repeating admissions for J codes in each
year.
Duration of hospitalisation
In the second set of analyses, for each ﬁrst admission of
an ID case with respiratory system disease in the observa-
tion period (1 January 2008 to 31 March 2013), four
controls with their ﬁrst admission of respiratory system
disease (ICD-10 J-code) as primary discharge diagnosis
were randomly selected from the catchment data,
matched by age at admission and gender. Linear regres-
sion was used to model the duration of hospitalisation as
the outcome, taking into account the matched design by
specifying the group id for each group of cases and
matched controls in Stata command.
Risk of repeat hospitalisation
The third set of analyses was restricted to ﬁrst hospital
admissions in the observation period for people residing
in the SLaM catchment. The analysed sample comprised
people with respiratory system diseases as a primary dis-
charge diagnosis; the analysis compared those with/
without an ID diagnosis using a binary independent vari-
able; and the outcome was a further admission for
respiratory system disease after discharge, analysed using
the Cox models. The follow-up period was deﬁned by the
date of discharge for the index admission as the starting
point and date of the next respiratory system disease
admission (‘event’ in survival analysis) with 31 March
2013 (end of the observation period) as censoring. Two
adjacent hospitalisation episodes within 2 days were con-
sidered as one admission and those who died in the
index admission were excluded. Ethnicity, discharge
method for the index admission (‘clinical advice/clinical
consent’, ‘self-discharged/others’ or ‘death’) and
number of physical comorbidities other than respiratory
system diseases were considered as potential confounders.
All analyses were carried out using Stata V.12.1
(StataCorp., College Station, Texas, USA) and an α level
of 0.05 was used as the criterion for statistical signiﬁcance.
RESULTS
Study sample characteristics
Using the CRIS data resource, a total of 3138 adults with
ID aged at least 20 years old were identiﬁed, which
represented 1.6% of adults on the database; this sample
was 55.5% men with a mean age of 44.9 years (SD 17.1).
The majority groups were mild (ICD 10 code F70,
n=1032; 32.89%) and moderate (F71, n=701; 22.34%)
ID cases, followed by other or unspeciﬁed ID cases (F78
or F79, n=1087; 34.64%), and then severe or profound
cases (F72 or F73, n=318; 10.13%). Ethnicity coding for
the majority was white (59.0%), followed by black
(23.7%), which broadly reﬂects the ethnicity proﬁle in
the catchment from the 2011 UK Census (55.0% white,
24.7% black).30 Figure 1 summarises the groups and
data for analysis.
Standardised admission ratios
Of the 3138 adults with ID identiﬁed, 437 (13.9%) had
at least 1 admission for respiratory system disease, result-
ing in 1149 hospitalisation episodes in the observation
period with a SAR of 4.02 (95% CI 3.79 to 4.26), further
described by gender and subcategory in table 1.
Excluding repeat admissions in the same year, SARs
were 3.19 overall (95% CI 2.94 to 3.44) and nearly iden-
tical for men and women. While most of the raised
admission rates were accounted for by lung diseases due
to external agents (ICD-10 code: J60–70) with SAR as
high as 15.25 (95% CI 11.63 to 19.62; n=60), signiﬁcant
SARs were also found for inﬂuenza and pneumonia,
chronic lower respiratory diseases and other acute lower
respiratory infections.
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Table 1 Standardised respiratory system disease admission ratios for patients with intellectual disability (N=3138)*
Standardised admission ratios (95% CI; number of admissions)
Diagnosis in ICD-10 Total Male Female
Diseases of the respiratory
system (all J codes)
4.02 (3.79 to 4.26; n=1149)† 4.22 (3.88 to 4.57; n=579)† 3.84 (3.53 to 4.17; n=570)†
Influenza and pneumonia
( J09–18)
6.28 (5.46 to 7.19; n=208)† 5.55 (4.52 to 6.73; n=102)† 7.19 (5.89 to 8.70; n=106)†
Other acute lower respiratory
infections ( J20–22)
6.21 (5.21 to 7.35; n=135)† 6.45 (5.04 to 8.14; n=71)† 5.97 (4.60 to 7.62; n=64)†
Other diseases of upper
respiratory tract ( J30–39)
0.85 (0.54 to 1.26; n=24) 0.90 (0.52 to 1.47; n=16) 0.76 (0.33 to 1.49; n=8)
Chronic lower respiratory
diseases ( J40–47)
4.03 (3.74 to 4.33; n=733)† 4.61 (4.15 to 5.11; n=360)† 3.59 (3.24 to 3.98; n=373)†
Lung diseases due to
external agents ( J60–70)
15.25 (11.63 to 19.62; n=60)† 14.46 (10.13 to 20.01; n=36)† 16.60 (10.64 to 24.70; n=24)†
Other respiratory diseases
principally affecting the
interstitium ( J80-84)
1.34 (0.64 to 2.47; n=10) 1.34 (0.43 to 3.13; n=5) 1.34 (0.44 to 3.14; n=5)
Patient counts for all
J codes ‡
3.19 (2.94 to 3.44; n=640)† 3.15 (2.81 to 3.52; n=306) † 3.22 (2.88 to 3.58; n=334)†
*Standard population: residents in London boroughs of Southwark, Croydon, Lambeth and Lewisham in 2011 UK Census.
†Statistical significance.
‡Repeating admissions for respiratory system diseases in the same fiscal year were removed.
Figure 1 Process for
identification of study sample and
comparison groups in statistical
analysis.
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Duration of hospitalisation
Preliminary analyses on the considered factors inﬂuen-
cing the duration of hospitalisation for respiratory
system diseases by comparing inpatients with ID (n=437)
and controls (n=1748) matched by age at admission and
gender are shown in table 2. The mean duration of ﬁrst
hospitalisation in the observation period was signiﬁ-
cantly longer for those with ID (11.72 days, SD=23.86)
compared with that for controls (9.08 days, SD=15.90).
Ethnicity, discharge method and number of comorbid-
ities also differed signiﬁcantly between the comparison
groups. Table 3 displays the results of univariate and
multivariate linear regressions for duration of hospital-
isation as the dependent variable. After adjustment for
ethnicity, discharge method and number of physical
comorbidities in the ﬁnal linear model, duration of hos-
pitalisation remained signiﬁcantly longer in the ID
group by 2.34 days (95% CI 0.03 to 4.64).
Risk of readmission
In the analysis of respiratory system disease readmission
rate (table 4), after excluding fatalities in the ﬁrst admis-
sion (n=40), a total of 397 adults with ID were identiﬁed
as having at least 1 admission with a respiratory system
disease as a primary discharge diagnosis. Of these, 184
experienced a further hospitalisation for a respiratory
system disease, and were compared with 62 286 non-ID
counterparts with 23 432 readmissions over the observa-
tion period. The unadjusted HR for readmission for
respiratory system disease was 1.36 (95% CI 1.18 to
1.57), which was not substantially altered in strength
following adjustment for age, gender, ethnicity, dis-
charge method and number of physical comorbidities.
DISCUSSION
Summarised key findings
In a large linked data set covering a deﬁned geographic
catchment, we found ID to be associated with increased
risk of hospitalisation for respiratory system diseases,
increased duration of hospitalisation and increased risk
of readmission. More speciﬁcally, among the 3138 adults
identiﬁed with ID from this secondary mental health
data resource, a more than fourfold increased frequency
of hospitalisation with all respiratory system diseases
combined (all J codes in ICD-10) was found based on
1149 episodes recorded during the 63-month observa-
tion period. We considered the possibility that a rela-
tively small number of adults with ID might account for
most of these admissions; however, after the exclusion of
ICD-10 J-code episodes in the same year, the relative risk
remained over threefold higher. The average duration of
hospitalisation for respiratory system diseases in adults
with ID was also longer than their matched counterparts
by 2.34 days after adjustment, and a 35% higher risk of
readmission with a respiratory system disease was also
identiﬁed.
Public health implications
Our analyses provide further evidence on the impact of
ID in terms of its medical burden, although more inter-
vention studies are needed to generate prevention
Table 2 Descriptive data on people in the first hospitalisation with a respiratory system disease, comparing those with
intellectual disability (ID) and age-matched and gender-matched non-ID controls
Variables
Mean±SD/number (%)
p Value *Adults with ID (n=437) Non-ID adults (n=1748)
Age at admission (years old) 54.59±19.82 54.57±19.81 –
Gender
Female 232 (53.09) 928 (53.09) –
Male 205 (46.91) 820 (46.91)
Length of first hospital stay (days) 11.72±23.86 9.08±15.90 0.027†
Ethnicity
White 297 (67.96) 1104 (63.16) <0.001†
Black 45 (10.30) 291 (16.65)
South Asian 7 (1.60) 56 (3.20)
East Asian 9 (2.06) 47 (2.69)
Others/mixed/unknown 79 (18.08) 250 (14.30)
Discharge method
Clinical advice/clinical consent 397 (90.85) 1619 (92.62) <0.001†
Self-discharged/others 10 (2.29) 26 (1.49)
Death 30 (6.86) 103 (5.89)
Number of physical comorbidities
0–2 135 (30.89) 658 (37.64) <0.001†
3–4 124 (28.38) 442 (25.29)
5 or more 178 (40.73) 648 (37.07)
*Dependent t-tests for continuous variables and McNemar’s tests for categorical variables.
†Statistical significance.
–, Variables used for matching in study design.
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strategies speciﬁcally for respiratory system diseases in
primary and secondary care for this group.1 14 16 31 32
Annual health checks have been provided with incentives
in primary care for adults with ID in the UK as an inter-
vention resulting in higher general and speciﬁc health
assessments, and improved detection of new comorbid-
ities such as thyroid and gastrointestinal illnesses through
secondary care referrals.31 Differing from previously pub-
lished research,9 19 20 23–25 our study has concentrated on
ID populations identiﬁed by secondary mental
Table 3 Linear regression analyses of factors associated with duration of hospitalisation for first admissions with a
respiratory system disease, comparing intellectual disability (ID) and age-matched and gender-matched non-ID controls
B value (95% CI)
Variables
Separately entered
variables (unadjusted)
Simultaneously entered
variables (mutually adjusted)
Intellectual disability 2.64 (0.30 to 4.97)* 2.34 (0.03 to 4.64)*
Ethnicity
White Ref Ref
Black 0.25 (−2.49 to 3.00) 1.82 (−0.85 to 4.49)
South Asian 0.03 (−3.64 to 3.69) −0.45 (−3.68 to 2.78)
East Asian 1.61 (−4.07 to 7.29) 3.02 (−2.22 to 8.26)
Others/mixed/unknown −3.38 (−4.81 to −1.96)* −2.18 (−3.55 to −0.81)*
Discharge method
Clinical advice/clinical consent Ref Ref
Self-discharged/others −5.30 (−7.14 to −3.45)* −4.84 (−7.19 to −2.48)*
Death 7.91 (4.20 to 11.62)* 3.40 (−0.17 to 6.98)
Number of physical comorbidities
0–2 Ref Ref
3–4 2.59 (1.49 to 3.68)* 2.45 (1.28 to 3.62)*
5 or more 12.50 (10.66 to 14.34)* 12.03 (10.08 to 13.99)*
*Statistical significance.
Table 4 Cox regression analyses of readmission with respiratory system disease following first hospitalisation, comparing
people with/without intellectual disability (N=62 683)
Variables
Mean±SD/
number
Proportion of
readmission
HR (95% CI)
Separately entered
variables (unadjusted)
Simultaneously
entered variables
(mutually adjusted)
Intellectual disability
No 62 286 37.62% Ref Ref
Yes 397 46.35% 1.36 (1.18 to 1.57)* 1.35 (1.17 to 1.56)*
Age at 1st admission (years old) 58.61±20.90 – 1.017 (1.016 to 1.018)* 1.016 (1.015 to 1.016)*
Gender
Female 34 465 37.09% Ref Ref
Male 28 209 38.40% 1.05 (1.02 to 1.07)* 1.03 (1.01 to 1.06)*
Unknown 9 0.00% – –
Ethnicity
White 40 067 41.77% Ref Ref
Black 10 043 31.53% 0.71 (0.69 to 0.74)* 0.87 (0.83 to 0.90)*
South Asian 2115 36.45% 0.84 (0.78 to 0.91)* 0.92 (0.86 to 0.99)*
East Asian 1477 29.45% 0.66 (0.60 to 0.72)* 0.77 (0.70 to 0.85)*
Others/mixed/unknown 8981 27.93% 0.62 (0.59 to 0.64)* 0.71 (0.68 to 0.74)*
Discharge method
Discharged on clinical advice/clinical
consent
61 602 37.56% Ref Ref
Self-discharged, or by a
relative/advocate
1059 44.48% 1.26 (1.15to 1.38)* 1.43 (1.31 to 1.57)*
Others 22 45.45% 1.51 (0.81 to 2.80) 1.64 (0.88 to 3.04)
Number of physical comorbidities
0–8 21 772 40.58% Ref Ref
9 or more 40 911 36.13% 0.79 (0.77 to 0.81)* 0.84 (0.82 to 0.86)*
*Statistical significance.
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healthcare services. Adults whose ID is more likely to be
moderate or mild were therefore found to be at a higher
risk of respiratory system disease requiring hospital admis-
sion. People with severe ID and multiple disabilities were
reported at a higher risk of hospital admissions for aspir-
ation pneumonia ( J60–70) and premature deaths,33 sug-
gesting congenital abnormalities, and diseases of the
nervous system and sense organs could be the main
underlying problem. Although low birth weight and
preterm birth have been well characterised as underlying
lung diseases in children with ID,33 further research is
required on factors accounting for increased respiratory
system disease in adults. For this cohort, respiratory infec-
tion was a major cause of admission, which might well be
amenable to early intervention and public health strat-
egies such as inﬂuenza vaccination.
Mental healthcare implications
The study cohort consisted of adults with ID; a secondary
mental healthcare provider might be selectively choose
those with less severe levels of ID and higher psychiatric
comorbidities. Traditionally, delays in accessing physical
healthcare were thought to be largely due to difﬁculties
recognising symptoms by the individual with ID or their
carers. However, the CIPOLD in the UK declared that
while adults with ID presented to healthcare services,
there were delays in diagnosis and treatment.14 Since the
prevalence of adulthood ID is reported around 2% in
England,2 the catchment area for SLaM has 1 369 048 resi-
dents older than 20 years (2011 UK Census data) and thus
can be expected to contain 27 381 individuals with ID.
The prevalence of mental disorders in the adult ID popu-
lation is reported to be between 20% and 40%, depending
on in the inclusion of ‘challenging behaviours’.34 Thus,
the cohort size of 3138 individuals on our CRIS database
would suggest that a signiﬁcant number of adults with ID
are either not known to, or not identiﬁed by, mental
health services. Adults with ID involved in our analysis
were limited to the ones with mild to moderate ID and
may be comorbid with other mental disorders, which
restricted the generalisability of our outcomes to people
with ID with a wide range of severity. However, since the
ID cases in our analyses were presumably milder than the
whole ID population and we could reasonably envisage
that the situation of respiratory system diseases admission
is worse along with the severity of ID, the signiﬁcant results
revealed in our analyses might have been rather conserva-
tive and the real effect sizes should be even bigger.
Potential solutions for improvement
Enhancement of education of doctors and nurses with
more ID health content in their curriculum might be of
most importance to improved healthcare for people with
ID.35 36 However, a survey in 2006 of six European coun-
tries (Finland, Germany, the Netherlands, Norway,
Sweden and the UK) and Australia, Canada, Japan and
the USA reported that attention to the speciﬁc health
aspects of ID in the total education programme for
medical students varied from 0 to 36 hours. In most coun-
tries, there is no speciﬁc attention, and just general infor-
mation spread over Psychiatry, Paediatrics and Medical
Genetics.37 Actions have been taken in the UK to
redesign the curriculum of undergraduate medical edu-
cation to address the issues about health inequalities for
people with ID, in order to increase knowledge, skills and
reducing stigmatisation.38 To certain extent, small-scale
intervention studies in primary care settings had shown
that feasible health checks might be able to meet health
monitoring needs and will be cost-efﬁcient for adults with
ID in Scotland.39 40 Besides, the effect of an interdiscip-
linary, guideline-based continuing education course for
primary care professionals to the care of adults with ID
was assessed in Canada. Signiﬁcant improvement was
identiﬁed in terms of the frequency of guideline use,
assessment of behaviour change, comfort level in caring
for people with ID and related knowledge.41 The devel-
opment of clinical guidelines for this particular group of
people, covering issues about promoting the integration
of healthcare services provided by primary and secondary
healthcare systems, health screening and continuing
education, might be of greater importance, too.42
Strengths and weaknesses of this research
This research beneﬁted by a large database from a near-
monopoly secondary mental healthcare provider in
southeast London with a linkage to national hospitalisa-
tion data on physical disorders, clinical diagnoses of ID
given by ID specialists working in secondary mental
healthcare, and a cohort study design. Nonetheless, some
important limitations require consideration. First, both
the databases analysed were established for the purpose
of administration and/or routine clinical practice, rather
than research, resulting in incomplete data including
those on lifestyle factors such as smoking, alcohol intake,
physical activity and obesity, which might be important
potential confounders. Second, while the number of
adults with ID identiﬁed in our mental health case regis-
ter is a recognisable and clinically relevant subset, it is
likely to be a marked underestimate of the population
with ID; thus, the generalisability of our current analysis
should be viewed with caution. However, as what was
further discussed in a previous paragraph, the potentially
conservative estimations shifting to null (but still statistic-
ally signiﬁcant) made our analysis outcomes even more
reliable. Third, although we identiﬁed 3138 adults with
ID and 640 of them had had at least 1 admission because
of respiratory system diseases, the statistical power for
further analyses on the duration of hospitalisation and
risk of readmission for all causes of respiratory diseases as
a whole was only barely enough to show signiﬁcance. So,
we were not allowed to look into speciﬁc respiratory
system diseases because of limited statistical power.
Concluding summary and directions of future research
Drawing a conclusion, people with ID accessing second-
ary mental healthcare services were at a higher risk of
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respiratory system diseases requiring hospitalisation com-
pared with the local general population, including
respiratory infections and chronic lower respiratory
disease. Once admitted, they had longer durations of hos-
pitalisation and were more likely to be readmitted with a
diagnosis of respiratory system disease. This suggests early
diagnosis and interventions, public health strategies and
lifestyle choices may be important in addressing their
health inequalities and poorer outcomes. Further studies
assessing the effect of potential prevention strategy (eg,
inﬂuenza vaccination) in the target population in second-
ary mental healthcare setting are warranted. Besides,
further research focusing on the evidence of delays or
barriers to diagnoses and treatments for physical illness
among people with ID, identifying healthcare needs and
accessing appropriate care in response to need changing
is also of great research interests.
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